Constellation Pharmaceuticals to Host Analyst/Investor Meeting at ASCO to Discuss Interim Update of Data of CPI-0610 in MANIFEST Clinical Trial

NEXT STORY
Robust Clinical Data and Positive Customer Experience with T2Bacteria and T2Candida Panels Highlighted at Recent Medical Meetings
PREV STORY
VBL Therapeutics Announces Presentations at the 2019 ASCO Annual Meeting and the BIO International Convention
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Team of International Scientists Identify Common Vulnerabilities Across SARS-CoV-2, SARS-CoV-1 and MERS Coronaviruses

author_avatar
NASDAQ Market News

UCB and Biogen Announce Topline Results from a Phase 2b Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus

BRUSSELS, Belgium and CAMBRIDGE, Mass., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Today UCB (Euronext ...

author_avatar
NASDAQ Market News

Dr. Lisa Johnson-Pratt Joins Akcea Therapeutics as Senior Vice President, New Product Strategy; Joshua Patterson promoted to General Counsel, adding to the company’s leadership team

author_avatar
NASDAQ Market News